VP, Regulatory Policy, Engagement & Intelligence

Mavericks Wanted When was the last time you achieved the impossible? read on In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way.

We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry.

" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical thoughtful use of AI to improve clarity, speed, and quality of work. Location: Washington, DC Work Schedule: Hybrid – minimum 3 days per week in office About BridgeBio BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers.

We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 20+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs. Our focus on scientific excellence and rapid execution aim to translate today’s discoveries into tomorrow’s medicines.

S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe.

Responsibilities

The VP, Regulatory Policy, Engagement Intelligence will report to the Chief Regulatory Officer and will be responsible for leading BridgeBio’s regulatory policy, agency engagement, and intelligence team. This role requires deep expertise in the regulatory landscape, strong relationships with global health authorities, and the ability to translate complex regulatory dynamics into clear, actionable strategy for the business. The VP will build and lead a team that can advance all three pillars of the function.

Regulatory Policy: The VP will oversee and drive efforts to monitor and shape the evolving policy landscape across FDA, EMA, and other relevant agencies. This includes tracking proposed rules, guidance developments, and agency initiatives; engaging with industry coalitions and trade associations; and developing BridgeBio’s positions on regulatory policy matters to inform internal strategy and external stakeholder engagement. Regulatory Engagement (FDA, EMA Global Health Authorities): A critical component of the role is to build and leverage relationships with regulatory agencies across the globe.

The VP will proactively engage with the FDA, EMA, and other international health authorities, shaping these interactions to advance our key programs, streamline regulatory pathways, and establish BridgeBio as a trusted and credible partner with regulators worldwide. Regulatory Intelligence Strategic Translation: The VP will lead efforts to systematically gather, synthesize, and translate regulatory intelligence into actionable strategy for the business.